BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BMS-986454 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BMS-986454\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07171983-5881@assetmemo.bio
DTSTAMP:20261121T005851Z
DTSTART;VALUE=DATE:20270628
DTEND;VALUE=DATE:20270629
SUMMARY:BMS-986454: Phase 1 readout est. (NCT07171983)
DESCRIPTION:BMS-986454\, phase 1\, Rheumatoid Arthritis.\nStudy: A Study to
  Evaluate the Safety\, Tolerability\, and Drug Levels of BMS-986454 in Par
 ticipants With Rheumatoid Arthritis\nEstimated primary completion: 28 June
  2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout dat
 e\, and it can move.\nDrug page: https://assetmemo.bio/drug/bms-986454#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0717198
 3
URL:https://assetmemo.bio/drug/bms-986454#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
